By Sabela Ojea
Science in Sport PLC said Wednesday that it performed ahead of expectations in 2021, delivering growth in revenue and underlying earnings before interest, taxes, depreciation and amortization.
The London-listed nutrition company said underlying Ebitda rose to 2.2 million pounds ($3 million) from GBP1.1 million in 2020.
Revenue increased by 25% to GBP62.7 million, with online sales rising by 40% to GBP35 million. Online sales via the group’s digital platforms were up by 28% and 53% via third-party marketplace sites.
“Prospects for further progress in 2022 look strong, and our long-term growth strategy remains unchanged,” Chief Executive Stephen Moon said.
Shares at 0941 GMT were up 1.50 pence, or 2.2%, at 70.00 pence.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
